Osmotica Pharmaceuticals PLC (OSMT) Actualités

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2023-06-15 2023-06-15 iso4217:USD...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2023-06-02 2023-06-02 iso4217:USD...

Quarterly Report (10-q)

00-0000000http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants http://www.rvlpharmaceuticals.com/20230331#FairValueAdjustmentOfDebt--12-31202...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2023-05-11 2023-05-11 iso4217:USD...

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant...

Proxy Statement (definitive) (def 14a)

TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 14AProxy Statement Pursuant to Section 14(a...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2023-03-20 2023-03-20 iso4217:USD...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2023-03-10 2023-03-10 iso4217:USD...

Confidential Treatment Order (ct Order)

Securities Registration Statement (simplified Form) (s-3)

  As filed with the Securities and Exchange Commission on January 27, 2023. Registration No. 333-    ...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2023-01-09 2023-01-09 iso4217:USD...

Quarterly Report (10-q)

0.130.2992756483629458988664304062798123000000-000000083297567991517060.160.420.391.010.160.280.390.72http://fasb.org/us-gaap/2022#FairValueAdjustm...